PubRank

Hans-Helge Seifert

Author PubWeight™ 27.79‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Robotic-assisted laparoscopic extended pelvic lymph node dissection for prostate cancer: surgical technique and experience with the first 99 cases. Eur Urol 2008 2.42
2 Tumour class prediction and discovery by microarray-based DNA methylation analysis. Nucleic Acids Res 2002 2.34
3 Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 2005 2.03
4 Laser fibre deterioration and loss of power output during photo-selective 80-w potassium-titanyl-phosphate laser vaporisation of the prostate. Eur Urol 2008 1.62
5 KPNA2 expression is an independent adverse predictor of biochemical recurrence after radical prostatectomy. Clin Cancer Res 2011 1.38
6 Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma. Genes Chromosomes Cancer 2002 1.28
7 Activities of MAP-kinase pathways in normal uroepithelial cells and urothelial carcinoma cell lines. Exp Cell Res 2003 1.21
8 Periostin is up-regulated in high grade and high stage prostate cancer. BMC Cancer 2010 1.21
9 Decrease of DNA methyltransferase 1 expression relative to cell proliferation in transitional cell carcinoma. Int J Cancer 2003 1.10
10 Multiple mechanisms downregulate CDKN1C in human bladder cancer. Int J Cancer 2005 0.98
11 Delayed infection of a pelvic lymphocele following robotic radical prostatectomy and pelvic lymphadenectomy: two cases. Urol Int 2009 0.93
12 Photoselective vaporization of the prostate: subgroup analysis of men with refractory urinary retention. Eur Urol 2006 0.91
13 Relationship of SNCG, S100A4, S100A9 and LCN2 gene expression and DNA methylation in bladder cancer. Int J Cancer 2008 0.91
14 Lithium triborate laser vaporization of the prostate using the 120 W, high performance system laser: high performance all the way? J Urol 2011 0.91
15 Hedgehog signaling in normal urothelial cells and in urothelial carcinoma cell lines. J Cell Physiol 2005 0.89
16 Clinical impact of 18F-choline PET/CT in patients with recurrent prostate cancer. Eur J Nucl Med Mol Imaging 2012 0.88
17 The Value of Prognostic Grouping of Prostatic Carcinomas for Urologists and Pathologists. Urol Int 2015 0.87
18 Decreased Fas expression in advanced-stage bladder cancer is not related to p53 status. Urology 2004 0.85
19 Detection of urothelial bladder cancer cells in voided urine can be improved by a combination of cytology and standardized microsatellite analysis. Cancer Epidemiol Biomarkers Prev 2009 0.85
20 Interdisciplinary evidence-based recommendations for the follow-up of testicular cancer patients: a joint effort. Swiss Med Wkly 2010 0.83
21 Laparoscopic extended pelvic lymph node dissection for high-risk prostate cancer. Urology 2006 0.82
22 Activity of E2F-dependent promoters in bladder carcinoma cells and their use for tumour-specific targeting of p53-induced apoptosis. Int J Oncol 2002 0.82
23 Discovery of TP53 splice variants in two novel papillary urothelial cancer cell lines. Cell Oncol (Dordr) 2012 0.81
24 Detection of circulating prostate cells during radical prostatectomy by standardized PSMA RT-PCR: association with positive lymph nodes and high malignant grade. Anticancer Res 2003 0.77
25 Ablative efficiency of 532-nm laser vaporization compared to transurethral resection of the prostate: results from a prospective three-dimensional ultrasound volumetry study. World J Urol 2013 0.77
26 Editorial comment on: Phase one pilot study using magnetic resonance spectroscopy to predict the histology of radiofrequency-ablated renal tissue. Eur Urol 2008 0.75
27 Denaturing high-performance liquid chromatography (DHPLC) as a reliable high-throughput prescreening method for aberrant promoter methylation in cancer. Hum Mutat 2004 0.75
28 Intrafascial dissection significantly increases positive surgical margin and biochemical recurrence rates after robotic-assisted radical prostatectomy. Urol Int 2012 0.75